Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation - Lazzerini, PE; Acampa, M; Capecchi, PL (Arthritis Care Res (Hoboken), 2015)
et al.